Phospho-CBX5 (Ser92) Antibody

What is CBX5 and what is the significance of its phosphorylation at Ser92?

CBX5 (also known as HP1α, Heterochromatin Protein 1 alpha) functions as a gene silencer that recognizes and binds histone H3 methylated at lysine 9 (H3K9me), leading to epigenetic repression . It's a component of heterochromatin that contributes to the association of heterochromatin with the inner nuclear membrane and is involved in kinetochore formation . The phosphorylation at Ser92 specifically regulates CBX5 function, though the precise mechanism requires further research. CBX5 has been identified as playing crucial roles in maintaining fibroblast activation in pulmonary fibrosis and possibly in mitotic regulation .

How does CBX5 contribute to epigenetic regulation?

CBX5 works in concert with histone methyltransferase G9a (EHMT2) to establish H3K9me marks and assemble a repressor complex, leading to gene silencing . Research demonstrates that the CBX5/G9a/H3K9me pathway represses the transcription of genes essential for returning lung fibroblasts to an inactive state, particularly through epigenetic repression of peroxisome proliferator–activated receptor γ coactivator 1α gene . This epigenetic repression mechanism is critical for sustaining activated states in pathological fibroblasts during disease progression.

In which cellular compartments is phosphorylated CBX5 (Ser92) typically found?

Phosphorylated CBX5 (Ser92) is primarily localized in the nucleus, specifically in chromosomes and centromeres . It colocalizes with hnRNPU in the nucleus and is a component of centromeric and pericentromeric heterochromatin . During the cell cycle, it associates with chromosomes during mitosis and specifically with chromatin during metaphase and anaphase . Additionally, it localizes to sites of DNA damage, suggesting a potential role in DNA repair mechanisms.

What are the recommended applications and dilutions for Phospho-CBX5 (Ser92) antibody?

The Phospho-CBX5 (Ser92) antibody is suitable for multiple applications:

• Immunohistochemistry (IHC): Recommended dilution of 1:50-1:100

• Enzyme-linked immunosorbent assay (ELISA): Recommended dilution of 1:40000

• Immunofluorescence (IF): Recommended dilution of 1:50-200

These recommended dilutions may vary between manufacturers, so researchers should perform optimization tests when using a new antibody lot or in a new experimental system.

How should researchers validate the specificity of Phospho-CBX5 (Ser92) antibody?

To validate specificity, researchers should:

• Perform peptide competition assays using blocking peptides containing the phosphorylated Ser92 epitope. For example, immunohistochemical analysis shows diminished staining when the antibody is preincubated with a blocking peptide .

• Include positive and negative controls:

  • A positive control might be cells/tissues known to express phosphorylated CBX5

  • A negative control could be samples treated with phosphatase to remove phosphorylation

  • Compare with samples where CBX5 expression is knocked down via siRNA

• Verify that the antibody detects endogenous levels of CBX5 only when phosphorylated at serine 92 by comparing with non-phospho-specific antibodies .

What storage conditions are optimal for maintaining antibody activity?

For unconjugated antibodies:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles

• Some preparations contain glycerol (typically 50%) which helps maintain stability

For conjugated antibodies (e.g., HRP-conjugated):

• Store in light-protected vials or covered with a light-protecting material (e.g., aluminum foil)

• Conjugated antibodies are typically stable for at least 12 months at 4°C

• For longer storage (up to 24 months), they may be diluted with up to 50% glycerol and stored at -20°C to -80°C

• Note that freezing and thawing will compromise enzyme activity and antibody binding

What role does phosphorylated CBX5 play in fibrosis progression?

CBX5 has been identified as a critical epigenetic repressor that contributes to lung fibroblast activation in response to both biochemical and mechanical stimuli . Research demonstrates that:

• CBX5 knockdown significantly attenuated TGF-β-induced profibrotic gene expression (ACTA2, COL1A1, FN1) in lung fibroblasts

• CBX5 silencing blocked αSMA expression and inhibited extracellular matrix (ECM) protein deposition

• CBX5 knockdown impaired cell migration in wound-healing assays

• In IPF-derived fibroblasts, CBX5 knockdown reduced profibrotic gene expression even without exogenous TGF-β stimulation

These findings suggest CBX5 plays a crucial role in both initiating and sustaining fibroblast activation by repressing genes that maintain or return fibroblasts to an inactive state.

How is CBX5 phosphorylation regulated during mitosis?

Systematic phosphorylation analysis of mitotic protein complexes reveals that CBX5 may be phosphorylated in a cell cycle-dependent manner . In a study of mitotic protein complexes:

• Phosphorylation sites were analyzed across different cell states: logarithmic growth (LOG), nocodazole arrest (NOC), PLK1 inhibition (BI), and Aurora B inhibition (Hesp)

• Most phosphorylation sites (400 out of 457) were found phosphorylated in mitotic cells

• About 34% of phosphorylation sites were predicted as targets of mitotic kinases, including PLK1 and AURKB

While the study doesn't specifically mention Ser92 phosphorylation of CBX5, it suggests that phosphorylation of proteins like CBX5 may be dynamically regulated during mitosis, potentially by mitotic kinases.

What is known about the kinases responsible for CBX5 Ser92 phosphorylation?

• PLK1 (Polo-like kinase 1) and AURKB (Aurora kinase B) are major mitotic kinases that phosphorylate numerous substrates during mitosis

• In a systematic phosphorylation analysis, PLK1 was responsible for 42 phosphorylation sites in 25 proteins, while AURKB was responsible for 20 phosphorylation sites in 18 proteins

Further research is needed to determine if these or other kinases are responsible for CBX5 Ser92 phosphorylation under different cellular conditions.

How can researchers integrate phosphorylated CBX5 studies with broader epigenetic mechanisms?

Researchers can integrate phosphorylated CBX5 studies into broader epigenetic research through:

• Chromodomain engineering approaches: Studies have developed high-affinity chromodomains for improved detection of methylated histones . Similar approaches could be used to study how CBX5 phosphorylation affects its interaction with methylated histones.

• Combined analysis with other heterochromatin marks: Investigate how CBX5 phosphorylation influences its binding to H3K9me and subsequent recruitment of other heterochromatin components .

• Genome-wide localization studies: Combine ChIP-seq using phospho-specific antibodies with transcriptome analysis to identify genes regulated by phosphorylated CBX5 .

• Bidirectional promoter regulation: The CBX5 gene shares a bidirectional promoter with hnRNPA1, suggesting complex regulatory mechanisms . Researchers could investigate how phosphorylation affects this relationship.

What experimental approaches can distinguish between different phosphorylated forms of CBX5?

To distinguish between different phosphorylated forms:

• Phospho-specific antibodies: Use antibodies that specifically recognize CBX5 phosphorylated at different sites (e.g., Ser92) .

• Phosphopeptide mapping: Mass spectrometry-based phosphoproteomics can identify and quantify multiple phosphorylation sites simultaneously .

• Mutation studies: Generate phospho-mimetic (S→D/E) or phospho-deficient (S→A) mutants of CBX5 to study the functional consequences of phosphorylation at specific sites.

• Peptide competition assays: Use synthetic phosphopeptides corresponding to different phosphorylation sites as competitors to determine antibody specificity .

• 2D gel electrophoresis: Separate different phosphorylated forms based on charge differences introduced by phosphorylation.

How might phosphorylation of CBX5 at Ser92 affect its interaction with other proteins?

While the search results don't directly address this question, we can infer potential effects based on CBX5's known functions:

• CBX5 interacts with the MIS12 complex subunit NSL1 in kinetochore formation . Phosphorylation might regulate this interaction during mitosis.

• CBX5 binds to H3K9me to mediate epigenetic repression but is excluded from chromatin when H3Y41 is phosphorylated . Ser92 phosphorylation might similarly affect its binding to histones.

• CBX5 may interact with the lamin-B receptor (LBR) to associate heterochromatin with the inner nuclear membrane . Phosphorylation could regulate this interaction.

• In the context of fibrosis, CBX5 works with G9a to repress gene expression . Phosphorylation might regulate the assembly or activity of this repressor complex.

What are common issues encountered when working with Phospho-CBX5 (Ser92) antibodies?

Common issues may include:

• Cross-reactivity: Ensure the antibody specifically detects CBX5 only when phosphorylated at Ser92 and not other phosphorylation sites or related proteins . Using non-phospho-specific antibodies as controls can help assess specificity.

• Low signal intensity: This could result from low expression levels of phosphorylated CBX5, suboptimal antibody concentration, or degradation of the phosphorylation mark. Try increasing antibody concentration, using signal amplification methods, or ensuring phosphatase inhibitors are present during sample preparation.

• High background: This might result from non-specific binding. Optimize blocking conditions and antibody dilutions, and include appropriate controls to identify sources of background.

• Inconsistent results: Phosphorylation status can change rapidly depending on cell cycle stage or cellular stress. Standardize sample collection and preparation protocols, and consider synchronizing cells when studying cell cycle-dependent phosphorylation.

How can researchers verify that observed signals truly represent phosphorylated CBX5?

To verify signal specificity:

• Peptide competition: Pre-incubate the antibody with a blocking peptide containing phosphorylated Ser92 . Signal disappearance confirms specificity.

• Phosphatase treatment: Treat samples with lambda phosphatase to remove phosphorylation. Disappearance of the signal confirms it was phosphorylation-dependent.

• siRNA knockdown: Silence CBX5 expression using siRNA . Absence of signal in knockdown samples confirms specificity for CBX5.

• Phospho-null mutants: Express CBX5 with Ser92 mutated to alanine (S92A). Absence of signal confirms specificity for phosphorylation at this site.

• Multiple antibodies: Use multiple antibodies from different sources that recognize the same phosphorylation site to confirm results.

What controls should be included in experiments using Phospho-CBX5 (Ser92) antibody?

Essential controls include:

• Positive control: Cell lines or tissues known to express phosphorylated CBX5 (e.g., TGF-β-stimulated fibroblasts or mitotic cells) .

• Negative controls:

  • Samples treated with phosphatase

  • Samples where CBX5 expression is knocked down via siRNA

  • Peptide competition controls

• Technique-specific controls:

  • For IHC/IF: Secondary antibody-only controls to assess background

  • For Western blotting: Loading controls and molecular weight markers

  • For ELISA: Standard curves and blank wells

• Physiological controls:

  • Compare different cell cycle stages if studying cell cycle-dependent phosphorylation

  • Include both stimulated (e.g., TGF-β) and unstimulated conditions when studying signaling pathways